Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Posted on: Aug/20/2020 19:09:09
NVS/GMABFDA approves Kesimpta(subcutaneous ofatumumab)for MS:
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157767340
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.